Fast-release lurasidone hydrochloride tablet and preparation process thereof

A lurasidone hydrochloride tablet and a preparation process technology are applied in the directions of medical preparations without active ingredients, medical preparations containing active ingredients, drug combinations, etc. And other issues

Inactive Publication Date: 2020-02-25
赵洁
View PDF9 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, compared with the above-mentioned pulverization and sieving method, micronization consumes more energy and is more dangerous, and the powder fluidity is poor, which limits the use of wet granulation, and the steps are cumbersome
In addition, the above-mentioned patents only paid attention to the dissolution of the preparation, but did not pay attention to the preparation stability of lurasidone hydrochloride
[0004] In order to overcome the drawba...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fast-release lurasidone hydrochloride tablet and preparation process thereof
  • Fast-release lurasidone hydrochloride tablet and preparation process thereof
  • Fast-release lurasidone hydrochloride tablet and preparation process thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] (1), take lurasidone hydrochloride 20g, mannitol 200g for subsequent use;

[0040] (2) Measure and mix 120mL of isopropanol and 60mL of water, dissolve lurasidone hydrochloride and 40g of mannitol in the above mixture to obtain a uniform and clear single-phase system A;

[0041] (3), 40g PVPK30 and remaining filler are added in the high-speed mixing granulator and mixed uniformly to obtain mixture B;

[0042] (4), adding the single-phase system A in the step (2) to the high-speed mixing granulator in the step (3), and discharging the dry granules after mixing, cutting and drying;

[0043] (5), the obtained tablet of direct compression tablet, totally 1000.

Embodiment 2

[0045] Concrete steps are identical with embodiment 1, and difference is that mannitol total amount is 160g;

Embodiment 3

[0047] Concrete steps are identical with embodiment 1, difference is that the consumption of water is 50mL;

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a lurasidone hydrochloride tablet which is used for treating severe depression related to bipolar I disorder of pediatric patients and can realize rapid and complete drug release and a preparation process of the lurasidone hydrochloride tablet. The drug and a part of diluent are dissolved in a mixed solvent of an organic solvent and water, then the drug and the part of diluent are mixed with remaining auxiliary materials at a high speed, dried, granulated and tableted to obtain the lurasidone hydrochloride tablet. Compared with the prior art, the lurasidone hydrochloride tablet is simple in preparation process, low in energy consumption, rapid to release and good in release repeatability, and the preparation is stable after accelerated test.

Description

technical field [0001] The invention relates to the field of pharmacy, in particular to a lurasidone hydrochloride tablet capable of rapid and complete drug release for treating severe depression associated with bipolar I disorder in pediatric patients and a preparation process thereof. Background technique [0002] Lurasidone Hydrochloride is an atypical antipsychotic drug developed by Sumitomo, Japan. It was approved by the FDA for the first-line treatment of schizophrenia on October 28, 2010. The trade name is Latuda, and the preparation form is a tablet. As of August 2019, there were 44 records about the drug in the US Orange Book; in addition, on January 3, 2019, the drug was approved by the FDA for the treatment of major depression associated with bipolar I disorder in pediatric patients. It can be seen that even after nearly 9 years of listing, the drug still has great potential in the subdivision of psychiatric diseases. At present, Sumitomo Pharmaceutical (Suzhou)...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/20A61K31/496A61K47/26A61K47/32A61K47/10A61P25/24
CPCA61K9/2013A61K9/2018A61K9/2027A61K31/496A61P25/24
Inventor 王慧段培锋张延蕊崔晴晴赵洁
Owner 赵洁
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap